about
Progress in the treatment of pulmonary metastases after liver transplantation for hepatocellular carcinomaTargeting Hepatocellular Carcinoma: What did we Discover so Far?Development of IGF signaling antibody arrays for the identification of hepatocellular carcinoma biomarkersGradually elevated expression of Gankyrin during human hepatocarcinogenesis and its clinicopathological significanceDysregulated hepatic bile acids collaboratively promote liver carcinogenesis.HDAC1 inactivation induces mitotic defect and caspase-independent autophagic cell death in liver cancerLong-term effects of ionizing radiation on gene expression in a zebrafish model.Prognostic significance of Cbx4 expression and its beneficial effect for transarterial chemoembolization in hepatocellular carcinoma.P15 gene methylation in hepatocellular carcinomas: a systematic review and meta-analysisAberrant methylation of SPARC in human hepatocellular carcinoma and its clinical implication.Altered CELF1 binding to target transcripts in malignant T cells.Early detection of hepatocellular carcinoma co-occurring with hepatitis C virus infection: A mathematical modelP53 and expression of immunological markers may identify early stage thyroid tumorsReactivation of mutant p53 by a dietary-related compound phenethyl isothiocyanate inhibits tumor growth.Farnesoid X receptor directly regulates xenobiotic detoxification genes in the long-lived Little mice.LBH589 Inhibits proliferation and metastasis of hepatocellular carcinoma via inhibition of gankyrin/STAT3/Akt pathway.Age-associated change of C/EBP family proteins causes severe liver injury and acceleration of liver proliferation after CCl4 treatments.Association between expression of Carboxypeptidase 4 and stem cell markers and their clinical significance in liver cancer development.Surgical resection and radiofrequency ablation initiate cancer in cytokeratin-19+- liver cells deficient for p53 and Rb.Mutations in the p53 Tumor Suppressor Gene: Important Milestones at the Various Steps of TumorigenesisRetinoic acid receptor-related receptor alpha (RORalpha) is a prognostic marker for hepatocellular carcinoma.FXR-Gankyrin axis is involved in development of pediatric liver cancer.The collagen triple helix repeat containing 1 facilitates hepatitis B virus-associated hepatocellular carcinoma progression by regulating multiple cellular factors and signal cascades.Farnesoid X receptor inhibits gankyrin in mouse livers and prevents development of liver cancer.LINE-1 methylation level and patient prognosis in a database of 208 hepatocellular carcinomas.The oncoprotein, gankyrin, is up-regulated in middle ear cholesteatoma.RB and p53 cooperate to prevent liver tumorigenesis in response to tissue damage.RNA Binding Protein CUGBP1 Inhibits Liver Cancer in a Phosphorylation-Dependent Manner.O-GlcNAcylation of histone deacetylases 1 in hepatocellular carcinoma promotes cancer progression.Exogenous hydrogen sulfide promotes hepatocellular carcinoma cell growth by activating the STAT3-COX-2 signaling pathway.Roles of p53 in extrinsic factor-induced liver carcinogenesisPARP1 activation increases expression of modified tumor suppressors and pathways underlying development of aggressive hepatoblastomagene function during hepatoma cells proliferation
P2860
Q26783827-F8194690-1D3D-48F1-9603-D948306C13BCQ28077283-C9A0337D-7DA8-4452-AE05-B1A22E269F78Q28484376-630CE1B6-D8A5-494A-922D-E8B541980EFFQ33851157-E69F2392-F04F-4E97-B2DB-E73844403A49Q33860653-14A99AD2-28AD-482F-9662-739A7A7CE82EQ34230019-F05649F1-2B2B-47F6-B6A5-D449A34A128DQ34920152-2F4324F2-B0FF-4834-944D-1F9EAE1652B4Q35274662-9AA8A320-427B-4982-AAE1-17360DED4F85Q35791747-2133703B-F8B3-44E8-AF3B-3D1BF837A6E4Q35929159-AB1B36CD-BA76-45A7-94C3-5C3DF36A49DEQ36072305-FC823076-C80D-462D-ADB4-D3383AD52DD8Q36815018-3AB0AF0B-4CC8-4511-8B00-CB4257BB3FB4Q37220281-B261F121-2AD6-42A6-BD96-5D3C800EED0FQ37294298-22399B1A-E7DC-43C8-B106-A97972A6821EQ37353652-BCAFEDE3-6E60-41A2-9F75-346610840614Q37369888-54E90B67-D209-4CCD-B179-222473A584EFQ37459214-C7F95261-7510-44A2-ACA7-9E6135BBDE84Q37604326-3ACF2580-0855-49BC-A723-67DAD675D61BQ37688118-65898973-7EA8-415E-B963-6AB5224A8445Q37903701-0377CC9F-8A49-4E45-86CC-476E81CD7E38Q38391821-E0D68B62-3B81-41C6-BF85-3E581E74F39CQ38768973-7C0CA436-2493-4C2B-BBA3-6873151FB39EQ38952536-0B2A13BE-A2EC-4248-B8F3-269A2C680EDEQ39240990-D2F1BEDF-D3F1-41E2-AACD-F9C65892B12AQ41699788-DFF81BC6-3511-4CF3-A5B6-4E75405877E5Q42453041-267C21B3-48C8-4723-8280-D74EC11B1A65Q43137700-0534984A-A18B-4FE2-BD45-1104E36C91CFQ50970430-8ABA687D-12AA-464E-BFC0-2E06996877ACQ55025669-C373E7D5-31FC-441C-BD5A-A9F0DFA12386Q55237821-B4E12585-C02D-4AC8-B540-E4F6D64C1590Q56972496-7D1550A5-6738-4111-9387-A053717FCE45Q57144042-7BCAE034-1BA7-49FE-89AB-500F03EEC4A0Q58697722-3D6530BD-4C25-493E-B171-80E595D7DCA2
P2860
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Intracellular signaling and hepatocellular carcinoma.
@ast
Intracellular signaling and hepatocellular carcinoma.
@en
type
label
Intracellular signaling and hepatocellular carcinoma.
@ast
Intracellular signaling and hepatocellular carcinoma.
@en
prefLabel
Intracellular signaling and hepatocellular carcinoma.
@ast
Intracellular signaling and hepatocellular carcinoma.
@en
P2093
P2860
P1476
Intracellular signaling and hepatocellular carcinoma.
@en
P2093
Lubov Timchenko
Nikolai A Timchenko
Polina Iakova
P2860
P356
10.1016/J.SEMCANCER.2010.09.001
P577
2010-09-17T00:00:00Z